Risk factor
Very poor trading liquidity
Profitability factor
Very strong margins and returns
About
PT Soho Global Health Tbk, together with its subsidiaires, operates as a healthcare company in Indonesia. It operates through Distributions, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and distribution and logistics services. It also offers body defense, stamina and vitality, brain nutrient, eye health, skin care, weight management, and wellness products; sells and markets medical devices and medical equipment products in the areas of wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics; and provides product registration, marketing intelligence, sales, and marketing support services. In addition, it provides contract manufacturing services for various dosage forms. The company was founded in 1946 and is headquartered in Jakarta, Indonesia.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, ove